The TELO-SCOPE study: Attenuating Telomere Attrition with Danazol. Is there Scope to Dramatically Improve Health Outcomes for Adults and Children with Pulmonary Fibrosis? (2020–2025)
Grant type:
NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need